Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant

[1]  S. Ladhani,et al.  Lower Risk of Multisystem Inflammatory Syndrome in Children (MIS-C) with the Delta and Omicron variants of SARS-CoV-2 , 2022, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  L. S. Schmidt,et al.  Risk and Phenotype of Multisystem Inflammatory Syndrome in Vaccinated and Unvaccinated Danish Children Before and During the Omicron Wave. , 2022, JAMA pediatrics.

[3]  Kristine Macartney,et al.  The seroprevalence of SARS‐CoV‐2‐specific antibodies in children, Australia, November 2020 – March 2021 , 2022, The Medical journal of Australia.

[4]  I. Shavit,et al.  Severity and Incidence of Multisystem Inflammatory Syndrome in Children During 3 SARS-CoV-2 Pandemic Waves in Israel. , 2022, JAMA.

[5]  A. Randolph,et al.  An Update on Multisystem Inflammatory Syndrome in Children Related to SARS-CoV-2 , 2021, The Pediatric infectious disease journal.

[6]  H. Marshall,et al.  Prospective characterisation of SARS-CoV-2 infections among children presenting to tertiary paediatric hospitals across Australia in 2020: a national cohort study , 2021, BMJ Open.

[7]  N. Dinsmore.  Paediatric Active Enhanced Disease Surveillance (PAEDS) 2019: Prospective hospital-based surveillance for serious paediatric conditions. , 2021, Communicable diseases intelligence.

[8]  M. H. Cheng,et al.  Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation , 2020, Proceedings of the National Academy of Sciences.